Reimbursement
To achieve a reasonable remuneration take the perspectives of key stakeholders on your value proposition and evidence early on. Starting in Germany we develop viable access routes to the reimbursement markets for your medical device or medicinal product.
Mentoring and consulting services include
-
Change in perspektive: Understanding the current market and legal environment of statutory and private health insurers. We look at your value proposition through the lens of payers, healthcare providers and patients.
-
Assessment of the eligibility of your innovation and your organization for the reimbursement market. We support you pitch your strengths and close gaps.
-
Development of cooperations with payers, healthcare providers and management companies, including selective contracts for special care (§ 140a SGB V), new forms of healthcare (§ 92a SGB V) and family doctor-centered care (§ 73b SGB V)
-
Going the fast-track to reimbursement: Preparation of your scientific evaluation concept for proving a positive healthcare effect of your digital health innovation (DiGA, DiPA, DMD).
-
Price negotiations: tranlating the quality of your evidence and the size of your positive healthcare effect into reasonable reimbursement outcomes.